#Contraception

A new snapshot of Gen Z family planning finds young adults are delaying parenthood into their late 20s and, worryingly, a significant share are relying on the withdrawal or “pull-out” method as a primary form of birth control. The findings, drawn from a survey by pregnancy test brand First Response and women’s media platform Her Campus and reported by the New York Post, underscore a generational rethinking of when to have children — and a risk calculus around contraception that health experts say could backfire. For Thailand, where the birth rate has plunged to historic lows, the mix of delayed childbearing and inconsistent contraceptive protection holds lessons for sex education, public health, and demographic policy.

Alarming new research reveals that Generation Z adults are increasingly delaying parenthood while simultaneously relying on ineffective contraceptive methods, creating a perfect storm of reproductive health risks that could significantly impact Thailand’s already plummeting birth rates. A comprehensive survey conducted by pregnancy test manufacturer First Response in collaboration with women’s media platform Her Campus discovered that nearly 37% of young adults favor the withdrawal or “pull-out” method as their primary contraceptive approach, despite medical evidence showing this technique fails for approximately one in five couples annually. These findings arrive at a critical moment for Thailand, where birth rates have collapsed to historic lows below population replacement levels, requiring urgent attention to both reproductive health education and family planning support systems.

A new study highlights a troubling trend among Gen Z: many are delaying parenthood while relying on withdrawal as a primary contraceptive. This method has a documented failure rate of about 20-22 percent with typical use, raising the risk of unintended pregnancies in the interim. In Thailand, where birth rates have fallen to historic lows, the findings underscore an urgent need for stronger reproductive health education and accessible family planning services.

The struggle to access contraception in the United States has become more difficult in recent years, prompting advocates in New York to devise novel solutions such as vending machines dispensing Plan B pills and other over-the-counter products on university campuses. As the national landscape of reproductive rights continues to shift—especially in the wake of clinic closures and new legal hurdles—New York’s approach offers fresh hope and urgent lessons for other regions, including Thailand, where access to reproductive healthcare is an ongoing concern.

A fresh wave of contraceptive access efforts is unfolding in New York, even as funding strains and policy shifts reshape services. At a large state university in upstate New York, emergency contraception is now available through a vending machine, helping reduce cost, stigma, and travel time. As clinics adapt to changing policies, these campus innovations provide practical models for health workers and policymakers worldwide, including Thailand, where reproductive services remain unevenly distributed.

A growing number of Thai women are choosing to skip their periods for months or years by using continuous birth control. New research and expert interviews show that this approach is safe and effective when medically supervised. This view counters myths circulating on social platforms. The scientific consensus now is clear: continuous hormonal contraception does not pose long‑term health risks and does not cause infertility.

Traditionally, the monthly bleed has been seen as a sign of normal reproductive health. A recent feature by a major outlet explains that hormonal birth control can be used with or without a withdrawal bleed. Pills, injections, implants, and rings can be taken in a way that avoids the placebo week. Leading obstetricians emphasize that there is no medical necessity for a period when using hormonal contraceptives. Their experience from decades of practice lends substantial credibility to these findings.

A new study published in BMC Public Health has cast a spotlight on Ghana’s journey in expanding access to modern family planning methods, drawing attention to both impressive achievements and lingering disparities over the past decade. The research, titled “Demand for family planning satisfied by modern methods in Ghana: trends and inequalities (2013–2022),” provides updated insights into how Ghana is addressing reproductive health—a topic with growing resonance for policymakers and public health experts across the developing world, including Thailand (BMC Public Health).

A new study in BMC Public Health examines Ghana’s decade-long journey to expand access to modern family planning. The research, titled Demand for family planning satisfied by modern methods in Ghana: trends and inequalities (2013–2022), highlights both notable progress and persistent gaps in reproductive health.

Data show a steady rise in the share of Ghanaian women whose demand for modern contraception is met. This trend reflects ongoing government and partner efforts to broaden services, diversify available methods, and boost public awareness. The findings align with global targets that emphasize universal access to reproductive health under Sustainable Development Goal 3.

A sweeping funding freeze by the U.S. federal Title X family planning program has left key healthcare providers, including three Planned Parenthood clinics in Virginia, without critical support. The sudden move, announced in late March, raises concerns about access to affordable reproductive health services for low-income Americans. The policy shift could affect millions who rely on the half-century-old program for contraception, cancer screenings, STI testing, and pregnancy care.

Title X, established by Congress in 1970 and administered by the Department of Health and Human Services, funds a nationwide network of clinics that serve low-income and uninsured individuals with free or sliding-scale reproductive health care. Nationally, 297 Planned Parenthood clinics participate in Title X, with the freeze affecting clinics in multiple states and knocking out access in some communities altogether. Data from public health researchers show that in states where Title X providers form a backbone of care, people face longer wait times and reduced access to essential services.

Recent guidance from global health authorities warns that some medicines and dietary supplements can lower the effectiveness of hormonal birth control. For Thai readers, understanding these interactions is essential as access to medicines and over-the-counter products expands nationwide.

Hormonal birth control—pills, patches, injections, or implants—remains a popular and reliable option for family planning in Thailand. Yet new evidence and official health warnings highlight several common substances that can diminish efficacy. Everyday medicines or herbal remedies bought at pharmacies, traditional vendors, or online can influence how well contraception works, making informed choices crucial for safe reproductive health.

Some common medicines and dietary supplements could reduce the effectiveness of hormonal birth control, putting Thai women at unseen risk of unintended pregnancies, according to updated research and expert guidance from global health agencies. The expanding use of both pharmaceuticals and over-the-counter supplements in Thailand means understanding these interactions is more important than ever.

Hormonal contraceptives—whether pills, patches, injections, or implants—remain among the most popular choices for family planning in Thailand, recommended by healthcare providers for their convenience and high success rate. However, new evidence and official health warnings reveal that a handful of widely-used substances can lower the reliability of these contraceptives, sometimes drastically. For Thai readers, recognizing how everyday medicines or herbal remedies—often purchased at pharmacies, traditional medicine vendors, or online—can compromise birth control is crucial for informed, safe reproductive health choices.

A team of engineers from MIT, in collaboration with Brigham and Women’s Hospital, has developed an innovative drug delivery system that could significantly extend the duration of drug efficacy, a breakthrough that may transform patient care globally. The study, published in Nature Chemical Engineering, reveals methods to achieve long-lasting medication effects through simple, injectable formulations. This advancement is particularly impactful in the context of developing nations, where access to healthcare services and resources can be limited.

A collaboration between MIT engineers and Brigham and Women’s Hospital has introduced an injectable drug-delivery system that sustains medication effects for months or years. Published in Nature Chemical Engineering, the study demonstrates how simple formulations can achieve longer-lasting treatment, offering potential benefits for health systems facing access challenges, including Thailand.

Led by mechanical engineering professor Giovanni Traverso, the MIT team envisions depots that form after a minimally invasive injection and release drugs steadily over extended periods. The concept grew from a Gates Foundation initiative aimed at expanding contraceptive options in resource-limited settings. Vivian Feig, formerly an MIT postdoc and now a faculty member at Stanford, helped merge implant stability with the convenience of injections.